Specialty drugs: a distinctly American phenomenon
Naci, H.
& Kesselheim, A. S.
(2020).
Specialty drugs: a distinctly American phenomenon.
New England Journal of Medicine,
382(23), 2179 - 2181.
https://doi.org/10.1056/NEJMp1909513
& Kesselheim, A. S.
(2020).
Specialty drugs: a distinctly American phenomenon.
New England Journal of Medicine,
382(23), 2179 - 2181.
https://doi.org/10.1056/NEJMp1909513
Various stakeholders in the pharmaceutical supply chain assign the specialty label to drugs on the basis of a combination of several unrelated factors, including whether a drug treats a rare condition. But the single most common feature of specialty drugs is high cost.